(Q71816819)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

T Sanger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

W Satterlee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

G Tollefson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P Tran

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S Hamilton

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

159-167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02245617

21 October 2019

exact match

0 references

cites work

Dopamine receptor pharmacology

1 reference

12 December 2020

The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent

1 reference

12 December 2020

A rating scale for drug-induced akathisia

1 reference

12 December 2020

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

12 December 2020

Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidate

1 reference

12 December 2020

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

12 December 2020

Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule

1 reference

12 December 2020

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

12 December 2020

A rating scale for extrapyramidal side effects

1 reference

12 December 2020

Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245617

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8935812%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference